Europe Failed Miserably With Vaccines. Of Course It Did.

A certain kind of failure is baked into the E.U.’s institutional DNA.

#astrazeneca-plc, #coronavirus-2019-ncov, #european-commission, #european-union, #france, #germany, #macron-emmanuel-1977, #pfizer-inc, #sanofi-sa, #vaccination-and-immunization, #von-der-leyen-ursula

What Would It Take to Vaccinate the Whole World? Let’s Take a Look.

Big-power muscle flexing helps explain much of the world’s vaccine inequities, but there’s another reason behind insufficient doses: The challenge of making them is unprecedented.

#coronavirus-2019-ncov, #johnsonjohnson, #moderna-inc, #pfizer-inc, #politics-and-government, #sanofi-sa, #serum-institute-of-india, #shortages, #vaccination-and-immunization

Where Europe Went Wrong in Its Vaccine Rollout, and Why

While Washington went into business with the drug companies, Europe was more fiscally conservative and trusted the free market.

#astrazeneca-plc, #brussels-belgium, #coronavirus-2019-ncov, #curevac-gmbh, #disease-rates, #europe, #european-commission, #european-union, #government-contracts-and-procurement, #pfizer-inc, #politics-and-government, #public-private-sector-cooperation, #sanofi-sa, #shortages, #slaoui-moncef-m, #vaccination-and-immunization, #von-der-leyen-ursula

U.S. and Pfizer Seal Deal for 100 Million More Vaccine Doses

The company agreed to deliver the additional doses of its coronavirus vaccine by the end of July, helping address a looming shortage.

#azar-alex-m-ii, #biontech-se, #coronavirus-2019-ncov, #coronavirus-aid-relief-and-economic-security-act-2020, #defense-production-act, #drugs-pharmaceuticals, #johnsonjohnson, #moderna-inc, #novavax-inc, #pfizer-inc, #sanofi-sa, #trump-donald-j, #vaccination-and-immunization

Pfizer Nears Deal to Provide More Vaccine Doses

The company could provide at least tens of millions of additional doses of a coronavirus vaccine under an agreement that would give it better access to the supplies it needs to expand manufacturing.

#astrazeneca-plc, #azar-alex-m-ii, #biontech-se, #bourla-albert, #coronavirus-2019-ncov, #defense-production-act, #drugs-pharmaceuticals, #johnsonjohnson, #moderna-inc, #novavax-inc, #perna-gustave-f, #pfizer-inc, #presidential-election-of-2020, #sanofi-sa, #trump-donald-j, #vaccination-and-immunization

Drug Makers Are Pulling Back From a Program to Help the Needy

Some pharmaceutical companies are scaling back their participation in a federally mandated drug discount program. State attorneys general are demanding that the administration take action.

#attorneys-general, #biden-joseph-r-jr, #coronavirus-2019-ncov, #drugs-pharmaceuticals, #eli-lilly-and-company, #equitas, #health-insurance-and-managed-care, #health-resources-and-services-administration, #sanofi-sa, #suits-and-litigation-civil, #united-states-economy

Covid-19 Vaccines Offer Drug Makers Chance at Salvation, Financial and Beyond

Big profits beckon for pharmaceutical companies, which are already using their work on vaccines to fight efforts in Washington to curb drug prices.

#astrazeneca-plc, #clinical-trials, #coronavirus-2019-ncov, #curevac-gmbh, #drugs-pharmaceuticals, #glaxosmithkline-plc, #gorsky-alex, #johnsonjohnson, #merckcompany-inc, #novavax-inc, #pfizer-inc, #sanofi-sa, #vaccination-and-immunization

Sanofi and GlaxoSmithKline Snag Biggest Coronavirus Vaccine Deal Yet

The arrangement brings the Trump administration’s investment in coronavirus vaccine projects to more than $8 billion. The head of the federal effort is a former GSK executive.

#conflicts-of-interest, #coronavirus-2019-ncov, #glaxosmithkline-plc, #politics-and-government, #public-private-sector-cooperation, #sanofi-sa, #vaccination-and-immunization, #your-feed-science

Sanofi Accelerates Its Timeline for Coronavirus Vaccine Development

The French drugmaker is testing two types of vaccines in a bid to catch up to competitors.

#clinical-trials, #coronavirus-2019-ncov, #france, #glaxosmithkline-plc, #rna-ribonucleic-acid, #sanofi-sa, #vaccination-and-immunization, #your-feed-health, #your-feed-science

Trump’s Vaccine Chief Has Vast Ties to Drug Industry, Posing Possible Conflicts

Moncef Slaoui, a former pharmaceutical executive, is now overseeing the U.S. initiative to development coronavirus treatments and vaccines. His financial interests and corporate roles have come under scrutiny.

#appointments-and-executive-changes, #biotechnology-and-bioengineering, #boards-of-directors, #conflicts-of-interest, #coronavirus-2019-ncov, #drugs-pharmaceuticals, #ethics-and-official-misconduct, #glaxosmithkline-plc, #health-and-human-services-department, #moderna-inc, #research, #sanofi-sa, #securities-and-exchange-commission, #slaoui-moncef-m, #stocks-and-bonds, #trump-donald-j, #united-states-politics-and-government, #vaccination-and-immunization, #venture-capital, #your-feed-healthcare

Arthritis Drug Did Not Help Seriously Ill Covid Patients, Early Data Shows

The drug, sarilumab, sold as Kevzara, didn’t show benefits to patients who were hospitalized but not on ventilators. The study will continue with critically ill patients.

#clinical-trials, #coronavirus-2019-ncov, #drugs-pharmaceuticals, #regeneron-pharmaceuticals-inc, #sanofi-sa, #your-feed-healthcare, #your-feed-science